SureTrader
Home > Boards > US OTC > Medical - Healthcare >

Health Advance Inc (HADV)

HADV RSS Feed
Add HADV Price Alert      Hide Sticky   Hide Intro
Moderator: TheCBDMan
Search This Board: 
Last Post: 1/17/2018 6:01:25 AM - Followers: 30 - Board type: Free - Posts Today: 0

Bringing together organic and conventional solutions for health care & nutrition

Health Advance Inc. OTC: HADV

Website: http://HADVinc.com
Facebook: https://www.facebook.com/groups/HealthAdvanceInc
Twitter: http://twitter.com/healthadvanceco

Health Advance Company Video



https://youtu.be/smJ_g-S7Cxo

Company Overview

 

Health Advance Inc. (the “Company” or “Health Advance”) was incorporated on April 14, 2010 in the State of Wyoming. The Company was originally an online retailer of home medical products with operations in Canada and the United States. 

In March 2017 the company began business with Micro Medtech Ltd., conducting research and development in biotechnology. 

Additionally, on August 18, 2017 the Company was incorporated in Colorado as a foreign corporation.

 Health Advance Inc. is a Wyoming corporation trading on OTC Markets under ticker symbol HADV. The company operates within the U.S. and Asia-Pacific as a developer and researcher for biotechnology, primarily focused on medical foods to treat pain and other severe illnesses usually treated with pharmaceutical drugs derived from opioids, in addition to developing dietary supplements to serve as alternatives for medicine.  Our strategy is to attract opportunities in the health care industry through the development of patented product formulations for medical foods Cebidofen and Polyoxyfen , and Gynspeq , a food additive made from botanical extract blends that include kava and mitrigyna speciosa. Furthermore, the Company will explore ways to use the product formulations through research studies and clinical trials with medical schools, research organizations, hospitals, and government agencies.  

Cebidiofen

Cebidiofen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464442) for a pharmaceutical food made from an NSAID alternative and botanical extract blends containing cannabidiol and kava tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).

Polyoxyfen

Polyoxyfen is a provisional patent pending, product formulations (USPTO Patent Pending Application No. 62464423) for a pharmaceutical food made from an NSAID alternative and a botanical extract blends containing mitragyna speciose tied to the production of the neurotransmitters that enable management and enhancement to sensory response to pain and inflammation, formulated by ingredients that are classified as Generally Recognized as Safe (GRAS) by the American Food and Drug Administration (FDA).

Current Research Pipelne

Our acquisition in North America of two patent pending product formulations, cebidiofen and polyoxyfen, in partnership with Micro Medtech, Ltd. have entered a phase two, product development plan with Nutrasource Diagnostics, Inc. for medical foods that meet Generally Recognized As Safe (GRAS) regulatory standards; a pipeline process that is planned to complete in late 2017. 

Hantian Labs (Pernding Aquisition)

Hantian Labs (www.hantianlabs.com) is an emerging global leader in anti-ageing and vitality nutraceutical products. Developed by a team of research scientists, athletes and beauty professionals, the Hantian line of tablets uses state-of-the-art age reversal technology to diminish the signs of ageing, whilst enhancing, enriching and extending the lives of their consumers. Products, including GHBurn and Alpha Elite are made at Hantian's GMP ISO 9001 and Informed Sports certified facility in the United Kingdom with the strictest quality standards. Hantian products are Medicines & Healthcare Products Regulatory Agency (MHRA) approved. Hantian also has licenses issued by the Minister of Health for Canada, issued under the authority of section 7 of the Natural Health Products Regulations, for its products GHBurn and Alpha Elite. 

 


Health Advance Inc.
685 Citadel Drive East, Suite 290
Colorado Springs, CO 80909
Phone: +1 (719) 466-6699

Corporate Contacts

Media Inquiries: media[at]hadvinc.com   
Career Opportunities: jobs[at]hadvinc.com   
Investor Relations: investors[at]hadvinc.com

 

http://www.faqs.org/sec-filings/120117/Health-Advance-Inc_S-1.A/

Update Company Info Business Description
 
Financial Reporting/Disclosure
Reporting Status SEC Filer 
Audited Financials Audited
Latest Report Not Available
Regulatory Agency Not Available
CIK 0001531477
OTC Market Tier OTCQB

Incorporated In: WY, USA
Year of Inc. 2010
Employees Not Available

                                                                                                                                                      Corporate Management

Dr. Muhammad Mukhtar, Ph.D. - Interim CEO

Dr. Muhammad Mukhtar Ph.D. has served as a professor at the American University of Ras Al Khaimah (AURAK), United Arab Emirates. Before his arrival at AURAK, he served as Vice Chancellor/Professor of three Universities in Pakistan concomitantly – a unique honor for any academic leader. Through his wise academic leadership and innovative governance, he converted a regional higher education institution in Pakistan to one of the top-ranked in the country. Dr. Mukhtar received his Masters and MPhil in the field of Biochemistry from Pakistan and his Ph.D. in biosciences from the Drexel University of Philadelphia, USA, and also completed a Graduate Certificate in Research Management from Thomas Jefferson University in Philadelphia, USA. He served in various academic/administrative positions in the USA on an outstanding scientist (O-1) visa. Dr. Mukhtar is also an avid researcher. His laboratory developed an in-vitro model of the human blood-brain barrier to study viral neuropathogenesis. Dr. Mukhtar as Principal or Co-Investigator has received several awards from organizations including American Diabetes Association, American Society for Microbiology, Diabetes Trust Foundation, US National Institutes of Health, Pfizer Pharmaceuticals (NYSE: PFE), and the Higher Education Commission of Pakistan. Human blood-brain barrier model developed in his laboratory is extensively used to understand ferrying of viruses into the brain and finding cures for neurological ailments.

Dr. Mukhtar holds specialized Certificates in Public Health and Bioinformatics. Committed to the role of technology in biomedical research, he serves as managing editor of Frontiers in Bioscience and is on the editorial board of several research journals. He feels pride in mentoring researchers, scientists, teachers and administrators and committed professionals aspiring to excel in their practical life. He has several research publications, including peer-reviewed research, review articles, invited articles, book chapters, commissioned articles and critiques to his credit. A book describing accomplishments of Dr. Mukhtar's educational leadership has been published in Urdu language entitled "Hayat Zauq e Safar Kay Siwa Kuch Aur Naheen" and it's English Version "The Making of a Best National University" is in progress.

Greg Shusterman - Chairman 

Mr. Shusterman is a Canadian citizen who has worked previously in various senior leadership positions for a number of companies in the healthcare industry and has work experience as the Vice Chairman and ‘Acting Chairman’ for the Company since being elected in April of this year.

 

Christian Deisveld - Director

Mr. Diesveld is a Canadian citizen and UK resident who has worked previously in various senior leadership positions for a number of companies, including, but not limited to, Hantian Labs Limited, a recent acquisition of the Company, where Mr. Diesveld was recently named UK CEO of the Year – Small Enterprise in the Health and Wellness sector.


Dr. Christian Hong - Clinical Research Adviser, Project KLEAN

Dr. Hong currently serves as the President of New Tokyo Medical College in Micronesia and is a former AMEDD (Army Medical Department) officer, Dr. H. Christian Hong was nominated by Board of Regents on May 2012 to serve as president of New Tokyo Medical College. His nomination was confirmed by the Board of Regents the same month and he was sworn in as the first president of New Tokyo Medical College.

Prior to his New Tokyo Medical College appointment, Dr. H. Christian Hong served as Chief of Immunology, Brooke Army Medical Center (BAMC), San Antonio, Texas. Other assignments include Principal Investigator (as a Captain) at Department of Radiation Medicine, Armed Forces Radiobiology Research Institute, Uniformed Services University, Bethesda, Maryland, and Captain, Walter Reed Army Institute of Research, Walter Reed Army Medical Center, Washington, District of Columbia.

Dr. Hong holds Diploma from U.S. Army Academy of Health Sciences; graduate and doctorate degree from New York Medical College, New York and Nova Southeastern University, Florida respectively. Additionally, he holds a professional degree in medicine. Dr. Hong was awarded Meritorious Service Medal, Joint Service Commendation Medal, Army Commendation Medal, and Army Achievement Medal.

In November 2017 Dr. Hong was appointed the Head of Project KLEAN, a cooperative founded by New Tokyo Medical College, Micro Medtech, and Health Advance in efforts to develop opioid alternatives.

 

                                                                                                                                        Our News & Media

December 28, 2017 - Health Advance Submits Multiple Filings to SEC in Efforts to Bring the Company Current Following Change in Management 

September 7, 2017 - Health Advance Files Updates to SEC for Most Recent Quarterly 10-Q Report 

June 14, 2017 - Health Advance Announces New Management in Most Recent 10Q

May 1, 2017 - Health Advance Inc. - Polyoxfen Vs. Oxycodone: Could Kratom End Opiates Addiction?

March 29, 2017 - Drugs Derived from Kratom & Cannabis focus on New Organic Market Research Study for Pain Medicine Solutions

Feb 27, 2017 - Health Advance Inc. Announces $7 Million Financing Agreement with GHS Investments  

Jan 17, 2017 - Health Advance Announces the Closing of the Acquisition of Hantian Labs

## COMPANY NEWS ## 
Market Stream: http://www.nasdaq.com/symbol/HADV/stream 
Latest news:
http://www.otcmarkets.com/stock/HADV/news  
http://finance.yahoo.com/q/h?s=HADV+Headlines 
http://www.marketwatch.com/investing/Stock/HADV/news?CountryCode=US

## FUNDAMENTALS ## 
SEC Filings http://www.nasdaq.com/symbol/HADV/sec-filings 
Latest filings: http://www.otcmarkets.com/stock/HADV/filings 
Latest financial: http://www.otcmarkets.com/stock/HADV/financials 
Short Interest: http://www.nasdaq.com/symbol/HADV/short-interest 
OTC Short Report: http://otcshortreport.com/index.php?index=hadv 
Short Sales: http://www.otcmarkets.com/stock/HADV/short-sales 
Key Statistics: http://finance.yahoo.com/q/ks?s=HADV+Key+Statistics 
Insider Roster: http://finance.yahoo.com/q/ir?s=HADV+Insider+Roster 
Income Statement: http://finance.yahoo.com/q/is?s=HADV

SureTrader
HADV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#747   $HADV News Out!! Health Advance Appoints New Executive TheCBDMan 01/17/18 06:01:25 AM
#746   Cebidiofen & Polyoxyfen $HADV, in my opinion, this TheCBDMan 01/10/18 10:09:28 PM
#745   Last @ $0.05650 +(8.65%) TheCBDMan 01/10/18 11:15:07 AM
#744   In November 2017 Dr. Hong was appointed the TheCBDMan 01/09/18 11:59:25 PM
#743   $HADV Company Overview TheCBDMan 01/09/18 11:54:23 PM
#742   Hope the future is bright for HADV! Been Whispering Ranger 01/09/18 06:33:33 PM
#741   As of Friday HADV or Health Advance is TheCBDMan 01/02/18 03:14:08 AM
#739   Will they go straight QB or otc pink first StockStarGucci 12/29/17 07:34:12 PM
#738   HUGE Plans for HADV!!! TheCBDMan 12/29/17 07:25:33 PM
#737   Added some .04 and .035 today do they StockStarGucci 12/29/17 07:22:11 PM
#736   $HADV No more shares on SALE for 2017! TheCBDMan 12/29/17 07:20:53 PM
#735   Starkman also told me he had no clue StockStarGucci 12/29/17 02:29:07 PM
#734   You make some VERY VERY BOLD statements that TheCBDMan 12/28/17 07:33:10 PM
#733   NEWS: $HADV Health Advance Submits Multiple Filings to TheCBDMan 12/28/17 04:09:45 PM
#732   Took a loss on this one. Can’t reach Skyfire 12/25/17 07:11:44 AM
#730   #ALERT !! 8K FILLED $HADV Health Advance Inc. TheCBDMan 11/22/17 05:38:10 AM
#729   HADV - Solution? - Opioid addiction is the TheCBDMan 11/13/17 12:40:48 PM
#728   Great Video on Opioid Addiction, Just more info TheCBDMan 11/01/17 02:52:20 AM
#727   Health Advance Inc (HADV) Under the Watchful Eye TheCBDMan 10/31/17 05:21:10 PM
#726   HEALTH ADVANCE INCORPORATED (OTCMKTS:HADV)’s shares fetched interest from TheCBDMan 10/29/17 02:45:22 AM
#725   Wilder Moving Average Recorded Below the Simple Moving TheCBDMan 10/02/17 10:47:58 PM
#724   Spoke to Mr. Starkman this morning. Looks like Skyfire 09/13/17 10:44:31 AM
#723   Zeroing in on Yesterday’s High Point: Health Advance HADV TheCBDMan 09/13/17 03:34:21 AM
#722   Shares Seesawing on Volume: Health Advance (HADV) TheCBDMan 09/13/17 03:33:15 AM
#720   Technical Radar: SuperTrend Seen Above Stock Price for TheCBDMan 09/09/17 02:41:26 AM
#719   Starkman, FORMER President and Director - 8.01 from Filing TheCBDMan 09/08/17 03:23:47 AM
#718   HADV NEWS Out - SEC for Most Recent TheCBDMan 09/08/17 03:01:30 AM
#717   YES clearly from the Filing it is. TheCBDMan 09/08/17 02:58:17 AM
#716   HADV - SEC Reporting - Current Game on!! TheCBDMan 09/05/17 04:30:26 AM
#713  Restored IMO one should do proper DD on Greg Skyfire 08/31/17 04:27:18 PM
#711   I also hear the 10Q's filed are fraudulent Skyfire 08/29/17 06:27:44 PM
#709   This ticker is a joke and so is elkonig 08/28/17 03:23:11 PM
#708   It Seems HEALTH ADVANCE INCORPORATED ($HADV) Will Go Up TheCBDMan 08/18/17 12:54:41 PM
#707   HADV Jordan Starkman Lawsuit TRO Temporary Restraining Order TheCBDMan 08/15/17 09:25:36 AM
#706   $HADV Plan of Operation TheCBDMan 08/15/17 09:23:11 AM
#705   $HADV ~ Things that make you go hmm.... TheCBDMan 08/15/17 09:00:10 AM
#704   After reading the 10Q how do you draw TheCBDMan 08/14/17 07:40:11 AM
#703   Thanks PickRick 08/13/17 12:18:18 PM
#702   BANKRUPTCY BanjoDave 08/13/17 08:01:25 AM
#701   #ALERT !! 10Q FILLED $HADV Health Advance Inc. TheCBDMan 08/11/17 03:50:22 PM
#700   $HADV Health Advance Inc. ~ In other industry TheCBDMan 08/10/17 12:44:17 PM
#699   I use mitragyna speciocia and if the get TICKERTREND 08/09/17 03:55:35 PM
#698   What does (pn) after the HADV ticker symbol represent? PickRick 08/09/17 09:21:40 AM
#697   Are these guys still waiting on an FDA Racket1 07/26/17 03:30:57 PM
#696   Technicals Placed Under Review For Shares of Health TheCBDMan 07/18/17 09:36:58 AM
#695   Sizing Up the MACDH For Health Advance Inc (HADV) TheCBDMan 07/18/17 09:36:16 AM
#694   Health Advance Inc ( https://www.otcmarkets.com/stock/HADV/quote [ta TheCBDMan 07/17/17 09:23:47 AM
#693   ($HADV) Sales of Legal Cannabis Products are Expected TheCBDMan 07/14/17 01:19:35 PM
#692   Health Advance Inc ($HADV) Moving 10.26% in Session TheCBDMan 07/14/17 12:57:27 PM
#691   Health Advance (HADV) $0.0449 +0.0039 (+9.51%) TheCBDMan 07/13/17 02:01:09 PM
PostSubject